Feasibility Study of Adjuvant Chemotherapy With S-1 (TS-1; Tegafur, Gimeracil, Oteracil Potassium) for Gastric Cancer

Gastric Cancer - Germany
doi 10.1007/s10120-004-0278-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Survival Analysis of Adjuvant Chemotherapy With S-1 Plus Cisplatin for Stage III Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2013English

Relapse-Associated microRNA in Gastric Cancer Patients After S-1 Adjuvant Chemotherapy

Oncology Reports
MedicineCancer ResearchOncology
2013English

Safety and Efficiency of TS-1 Based Chemotherapy for Elderly Patients With Advanced Gastric Cancer

The Showa University Journal of Medical Sciences
2006English

Delay in Initiation of Postoperative Adjuvant Chemotherapy With S-1 Monotherapy and Prognosis for Gastric Cancer Patients: Analysis of a Multi-Institutional Dataset

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

Erratum To: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer

Annals of Surgical Oncology
OncologySurgery
2015English

Adjuvant Treatment for Gastric Cancer: Chemotherapy Versus Radiation

Oncologist
Cancer ResearchMedicineOncology
2013English

S-1 With Leucovorin and Oxaliplatin for Advanced Gastric Cancer

The Lancet Oncology
Oncology
2016English

Adherence and Feasibility of 2 Treatment Schedules of S-1 as Adjuvant Chemotherapy for Patients With Completely Resected Advanced Lung Cancer: A Multicenter Randomized Controlled Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Successful Treatment of Advanced Gastric Cancer With TS-1 Followed by Curative Gastrectomy

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy